Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $82,119,756    

Indirect Value

  $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634 Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 14 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2006-08-07 4 B $4.03 $2,654 I/I 658 86,587 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-07 4/A B $4.03 $2,654 I/I 658 87,128 2.17 -
SGEN Seagen Inc Director   –       •       •   2008-03-14 4 B $8.06 $2,665 I/I 330 477,052 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-06-20 4 B $7.30 $2,672 I/I 366 133,927 1.42 -
INCY Incyte Corp Director   –       •       •   2009-03-05 4 B $2.16 $2,693 I/I 1,248 3,487,000 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-06-20 4 S $7.38 $2,700 I/I (366) 133,561 0 -
INCY Incyte Corp Director   –       •       •   2008-01-09 4 B $10.94 $2,703 I/I 247 281,862 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-07-28 4/A S $14.87 $2,707 I/I (182) 13,473 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-07-28 4 S $14.87 $2,707 I/I (182) 13,473 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-08 4 B $7.21 $2,712 I/I 376 190,583 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-24 4 B $16.31 $2,713 I/I 166 193,447 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-23 4 B $6.95 $2,725 I/I 392 97,933 1.42 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-09 4 S $13.00 $2,756 I/I (212) 89,500 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-10 4 S $13.00 $2,796 I/I (215) 466,766 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-01-10 4 B $4.83 $2,806 I/I 581 15,724 1.42 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-05-26 4 B $1.59 $2,821 I/I 1,778 163,775 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-07 4 B $5.72 $2,827 I/I 494 82,444 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-05 4 S $8.11 $2,842 I/I (349) 6,123 0 -
SGEN Seagen Inc Director   –       •       •   2008-03-12 4 B $7.98 $2,889 I/I 362 147,844 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-23 4 B $16.40 $2,903 I/I 177 193,281 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-11-05 4 S $12.05 $2,905 I/I (241) 38,822 0 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-04-27 4 B $2.06 $2,936 I/I 1,413 154,955 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-03 4 B $24.42 $2,938 I/I 120 1,253,773 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $2,944 I/I 453 98,836 1.42 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-11-13 4 S $12.02 $2,969 I/I (247) 34,864 0 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 14 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed